Literature DB >> 10747883

New beta -lactamase inhibitory protein (BLIP-I) from Streptomyces exfoliatus SMF19 and its roles on the morphological differentiation.

S G Kang1, H U Park, H S Lee, H T Kim, K J Lee.   

Abstract

A new beta-lactamase inhibitory protein (BLIP-I) from Streptomyces exfoliatus SMF19 was purified and characterized. The molecular mass of BLIP-I was estimated to be 17.5 kDa by gel filtration fast protein liquid chromatography. The N-terminal sequence was NH(2)-Asn-Ser-Gly-Phe-Ser-Ala-Glu-Lys-Tyr-Glu-Gln-Ile-Gln-Phe-Gly. BLIP-I inhibited Bacto(R) Penase (Difco), and plasmid encoded TEM-1 beta-lactamase, whereas it did not inhibit Enterobacter cloacae beta-lactamases. The K(i) value of BLIP-I against TEM-1 beta-lactamase was determined to be 0.047 nm. The gene (bliA) encoding BLIP-I protein was identified by screening a genomic library using an oligonucleotide probe with a sequence based on the N-terminal sequence of BLIP-I. Analysis of the nucleotide sequence revealed that the gene was 558 base pairs in length and encoded a mature protein of 157 amino acid residues preceded by a 29-amino acid signal sequence. Pairwise comparison of the deduced amino acid sequence showed 38% identity with BLIP of Streptomyces clavuligerus. Furthermore, the 49th amino acid residue of BLIP-I was identical to Asp-49 of BLIP that was characterized to be an important residue for the inhibitory activity of BLIP. A modified BLIP-I in which Asp-49 was replaced by alanine (D49A) was obtained by site-directed mutagenesis. The inhibitory activities of recombinant (r) BLIP-I and its D49A mutant derivative, expressed in Escherichia coli, were compared. The K(i) value of rBLIP-I against TEM-1 beta-lactamase was similar to that of wild-type BLIP-I, but the D49A mutation increased the K(i) of rBLIP-I inhibition approximately 200-fold. A disruption mutant of the bliA gene in S. exfoliatus SMF19 was obtained by replacing the wild-type bliA gene with a copy inactivated by inserting a hygromycin resistance gene. The disruption mutant showed a bald phenotype, indicating that the bliA gene plays a role in morphological differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747883     DOI: 10.1074/jbc.M000227200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  Nontraditional microbial bioactive metabolites.

Authors:  V Bĕhal
Journal:  Folia Microbiol (Praha)       Date:  2001       Impact factor: 2.099

2.  Identification and characterization of beta-lactamase inhibitor protein-II (BLIP-II) interactions with beta-lactamases using phage display.

Authors:  N G Brown; T Palzkill
Journal:  Protein Eng Des Sel       Date:  2010-03-22       Impact factor: 1.650

3.  BLIP-II Employs Differential Hotspot Residues To Bind Structurally Similar Staphylococcus aureus PBP2a and Class A β-Lactamases.

Authors:  Carolyn J Adamski; Timothy Palzkill
Journal:  Biochemistry       Date:  2017-02-16       Impact factor: 3.162

4.  BLIP-II is a highly potent inhibitor of Klebsiella pneumoniae carbapenemase (KPC-2).

Authors:  Nicholas G Brown; Dar-Chone Chow; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

5.  Identification of the β-lactamase inhibitor protein-II (BLIP-II) interface residues essential for binding affinity and specificity for class A β-lactamases.

Authors:  Nicholas G Brown; Dar-Chone Chow; Kevin E Ruprecht; Timothy Palzkill
Journal:  J Biol Chem       Date:  2013-04-27       Impact factor: 5.157

6.  The structure of BVU2987 from Bacteroides vulgatus reveals a superfamily of bacterial periplasmic proteins with possible inhibitory function.

Authors:  Debanu Das; Robert D Finn; Dennis Carlton; Mitchell D Miller; Polat Abdubek; Tamara Astakhova; Herbert L Axelrod; Constantina Bakolitsa; Connie Chen; Hsiu Ju Chiu; Michelle Chiu; Thomas Clayton; Marc C Deller; Lian Duan; Kyle Ellrott; Dustin Ernst; Carol L Farr; Julie Feuerhelm; Joanna C Grant; Anna Grzechnik; Gye Won Han; Lukasz Jaroszewski; Kevin K Jin; Heath E Klock; Mark W Knuth; Piotr Kozbial; S Sri Krishna; Abhinav Kumar; David Marciano; Daniel McMullan; Andrew T Morse; Edward Nigoghossian; Amanda Nopakun; Linda Okach; Christina Puckett; Ron Reyes; Christopher L Rife; Natasha Sefcovic; Henry J Tien; Christine B Trame; Henry van den Bedem; Dana Weekes; Tiffany Wooten; Qingping Xu; Keith O Hodgson; John Wooley; Marc André Elsliger; Ashley M Deacon; Adam Godzik; Scott A Lesley; Ian A Wilson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-03-05

Review 7.  Tackling the Antibiotic Resistance Caused by Class A β-Lactamases through the Use of β-Lactamase Inhibitory Protein.

Authors:  Warawan Eiamphungporn; Nalini Schaduangrat; Aijaz Ahmad Malik; Chanin Nantasenamat
Journal:  Int J Mol Sci       Date:  2018-07-30       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.